Search research articles
Contact Us
Filters
Showing results (291-300 of 315) with videos related to
Page
of 32
Sort By:
The Journal of Clinical Investigation
|
October 2, 2014
Ibrutinib treatment ameliorates murine chronic graft-versus-host disease
Jason A Dubovsky, Ryan Flynn, Jing Du, et al.
The Journal of Clinical Investigation
|
August 6, 2013
Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells
Ute E Burkhardt, Ursula Hainz, Kristen Stevenson, et al.
Blood Advances
|
October 31, 2025
No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse
H Moses Murdock, Haesook T Kim, Katie Maurer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 18, 2017
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation
Robert J Soiffer, Haesook T Kim, Joseph McGuirk, et al.
The New England Journal of Medicine
|
July 14, 2016
Ipilimumab for Patients with Relapse after Allogeneic Transplantation
Matthew S Davids, Haesook T Kim, Pavan Bachireddy, et al.
Blood
|
November 4, 2022
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings
Jacqueline S Garcia, Yael Flamand, Livius Penter, et al.
The Journal of Clinical Investigation
|
March 29, 2022
Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse
Roman M Shapiro, Grace C Birch, Guangan Hu, et al.
Blood
|
May 23, 2024
Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies
Matthew J Frigault, Charlotte E Graham, Trisha R Berger, et al.
Blood
|
February 28, 2022
BET-bromodomain and EZH2 inhibitor-treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes
Michael C Zaiken, Ryan Flynn, Katelyn G Paz, et al.
Nature Biotechnology
|
August 21, 2024
Systematic identification of minor histocompatibility antigens predicts outcomes of allogeneic hematopoietic cell transplantation
Nicoletta Cieri, Nidhi Hookeri, Kari Stromhaug, et al.
Page
of 32
Search research articles
Search
Showing results (291-300 of 315) with videos related to
Sort By:
Page
of 32
The Journal of Clinical Investigation
|
October 2, 2014
Ibrutinib treatment ameliorates murine chronic graft-versus-host disease
Jason A Dubovsky, Ryan Flynn, Jing Du, et al.
The Journal of Clinical Investigation
|
August 6, 2013
Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells
Ute E Burkhardt, Ursula Hainz, Kristen Stevenson, et al.
Blood Advances
|
October 31, 2025
No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse
H Moses Murdock, Haesook T Kim, Katie Maurer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 18, 2017
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation
Robert J Soiffer, Haesook T Kim, Joseph McGuirk, et al.
The New England Journal of Medicine
|
July 14, 2016
Ipilimumab for Patients with Relapse after Allogeneic Transplantation
Matthew S Davids, Haesook T Kim, Pavan Bachireddy, et al.
Blood
|
November 4, 2022
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings
Jacqueline S Garcia, Yael Flamand, Livius Penter, et al.
The Journal of Clinical Investigation
|
March 29, 2022
Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse
Roman M Shapiro, Grace C Birch, Guangan Hu, et al.
Blood
|
May 23, 2024
Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies
Matthew J Frigault, Charlotte E Graham, Trisha R Berger, et al.
Blood
|
February 28, 2022
BET-bromodomain and EZH2 inhibitor-treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes
Michael C Zaiken, Ryan Flynn, Katelyn G Paz, et al.
Nature Biotechnology
|
August 21, 2024
Systematic identification of minor histocompatibility antigens predicts outcomes of allogeneic hematopoietic cell transplantation
Nicoletta Cieri, Nidhi Hookeri, Kari Stromhaug, et al.
Page
of 32